[Effectiveness of the radiosensitizer cisplatin. A pilot study].
18 patients with advanced squamous cell carcinoma of the head and neck region were treated via chemotherapy and radio therapy. In this regimen cisplatinum was used as a radiosensitizer. The total remission rate was 94% while remission duration and survival could not be calculated. Severe clinical local toxicity occurred as a side effect.
Klima
A
A
HNO-Universitätsklinik, Frankfurt/Main.
Szepesi
S
S
D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D010865:Pilot Projects; D011832:Radiation Injuries / Q000209:etiology; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011879:Radiotherapy Dosage
D011838:Radiation-Sensitizing Agents; D002945:Cisplatin
Zur Wirksamkeit des Radiosensitizers Cis-Platin. Eine Pilotstudie.